What does DR. ALISON PO KEE LEE, NEFROLOGIE do?

DR. ALISON PO KEE LEE, NEFROLOGIE is a specialist medical practice in Edegem. Private Limited, started on 8 June 2015, 2 establishments.

What is the address of DR. ALISON PO KEE LEE, NEFROLOGIE?

The registered office of DR. ALISON PO KEE LEE, NEFROLOGIE is located at Renaat de Rudderlaan 14, 2650 Edegem.

Is DR. ALISON PO KEE LEE, NEFROLOGIE still active?

Yes. According to the CBE (30 September 2026) DR. ALISON PO KEE LEE, NEFROLOGIE is active, legal situation “Normale toestand”, started on 8 June 2015.

Is DR. ALISON PO KEE LEE, NEFROLOGIE registered on Peppol?

Yes, DR. ALISON PO KEE LEE, NEFROLOGIE is registered on the Peppol network with ID 0208:0631942132.

What is the enterprise number of DR. ALISON PO KEE LEE, NEFROLOGIE?

The enterprise number of DR. ALISON PO KEE LEE, NEFROLOGIE is BE0631942132.

When was DR. ALISON PO KEE LEE, NEFROLOGIE founded?

DR. ALISON PO KEE LEE, NEFROLOGIE was founded on 8 June 2015.

Who are the directors of DR. ALISON PO KEE LEE, NEFROLOGIE?

According to the 2025 annual accounts, the directors of DR. ALISON PO KEE LEE, NEFROLOGIE are: Alison Po Kee Lee.

Is DR. ALISON PO KEE LEE, NEFROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 June 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. ALISON PO KEE LEE, NEFROLOGIE make in 2025?

DR. ALISON PO KEE LEE, NEFROLOGIE posted a profit after taxes of € 287,595 in financial year 2025.

What is the revenue of DR. ALISON PO KEE LEE, NEFROLOGIE?

As a small company, DR. ALISON PO KEE LEE, NEFROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 379,538.

DR. ALISON PO KEE LEE, NEFROLOGIE (Private Limited)

Dossier DR. ALISON PO KEE LEE, NEFROLOGIE, printed on 30 September 2026 from databakkes.be/en/0631942132/dr-alison-po-kee-lee-nefrologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. ALISON PO KEE LEE, NEFROLOGIE from Edegem, company number BE0631942132, closed financial year 2025 with a result of € 287,595 after tax. For that financial year DR. ALISON PO KEE LEE, NEFROLOGIE recorded a gross margin of € 379,538 and equity of € 20,460. Compared with financial year 2024, the result moved from € 257,768 to € 287,595. Profitable, and profit is growing. The buffer shrank hard: equity is 93 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Shrank hard

€ 20,460

▼ 93% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 287,595

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 175,506

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 545,363 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 4,597

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,523

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,548

▼ 66% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 247,854 Gross margin 2022: € 247,854 First fiscal year in the series	€ 314,040 Gross margin 2023: € 314,040 ▲ 27% vs 2022 (€ 247,854) Favourable step	€ 340,673 Gross margin 2024: € 340,673 ▲ 8% vs 2023 (€ 314,040) Favourable step	€ 379,538 Gross margin 2025: € 379,538 ▲ 11% vs 2024 (€ 340,673) Favourable step	▲ 11%
Profit after taxes	€ 178,581 Profit after taxes 2022: € 178,581 First fiscal year in the series	€ 215,441 Profit after taxes 2023: € 215,441 ▲ 21% vs 2022 (€ 178,581) Favourable step	€ 257,768 Profit after taxes 2024: € 257,768 ▲ 20% vs 2023 (€ 215,441) Favourable step	€ 287,595 Profit after taxes 2025: € 287,595 ▲ 12% vs 2024 (€ 257,768) Favourable step	▲ 12%
Equity	€ 452,275 Equity 2022: € 452,275 First fiscal year in the series	€ 323,895 Equity 2023: € 323,895 ▼ 28% vs 2022 (€ 452,275) Unfavourable step	€ 278,228 Equity 2024: € 278,228 ▼ 14% vs 2023 (€ 323,895) Unfavourable step	€ 20,460 Equity 2025: € 20,460 ▼ 93% vs 2024 (€ 278,228) Unfavourable step	▼ 93%
Total debts	€ 22,384 Total debts 2022: € 22,384 First fiscal year in the series	€ 124,105 Total debts 2023: € 124,105 ▲ € 101,721 vs 2022 (€ 22,384) Unfavourable step	€ 15,026 Total debts 2024: € 15,026 ▼ 88% vs 2023 (€ 124,105) Favourable step	€ 294,416 Total debts 2025: € 294,416 ▲ € 279,390 vs 2024 (€ 15,026) Unfavourable step	▲ € 279,390
Cash	€ 246,548 Cash 2022: € 246,548 First fiscal year in the series	€ 382,155 Cash 2023: € 382,155 ▲ 55% vs 2022 (€ 246,548) Favourable step	€ 185,722 Cash 2024: € 185,722 ▼ 51% vs 2023 (€ 382,155) Unfavourable step	€ 175,506 Cash 2025: € 175,506 ▼ 6% vs 2024 (€ 185,722) Unfavourable step	▼ 6%
Retained profit	€ 433,675 Retained profit 2022: € 433,675 First fiscal year in the series	€ 305,295 Retained profit 2023: € 305,295 ▼ 30% vs 2022 (€ 433,675) Unfavourable step	€ 259,628 Retained profit 2024: € 259,628 ▼ 15% vs 2023 (€ 305,295) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 259,628) Unfavourable step	▼ 100%
Dividend	€ 70,588 Dividend 2022: € 70,588 First fiscal year in the series	€ 341,176 Dividend 2023: € 341,176 ▲ € 270,588 vs 2022 (€ 70,588) Unchanged	€ 303,435 Dividend 2024: € 303,435 ▼ 11% vs 2023 (€ 341,176) Unchanged	€ 545,363 Dividend 2025: € 545,363 ▲ 80% vs 2024 (€ 303,435) Unchanged	▲ 80%
Bank debt	€ 7,394 Bank debt 2022: € 7,394 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 7,394) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 474,660 Balance sheet total 2022: € 474,660 First fiscal year in the series	€ 448,000 Balance sheet total 2023: € 448,000 ▼ 6% vs 2022 (€ 474,660) Unchanged	€ 293,254 Balance sheet total 2024: € 293,254 ▼ 35% vs 2023 (€ 448,000) Unchanged	€ 314,876 Balance sheet total 2025: € 314,876 ▲ 7% vs 2024 (€ 293,254) Unchanged	▲ 7%

Key figures of DR. ALISON PO KEE LEE, NEFROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. ALISON PO KEE LEE, NEFROLOGIE?

What happened at DR. ALISON PO KEE LEE, NEFROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 287,595 (▲ 12% vs 2024). Source: NBB ↗
Dec 31, 2015 New establishment in Malle. KBO
2015 Alison Po Kee Lee became a director. NBB
Jun 8, 2015 New establishment in Brasschaat. KBO
Jun 8, 2015 Start of the company according to the CBE. KBO

In short

From € 178,581 profit in 2022 to € 287,595 profit in 2025.

Paid € 299,332 in corporate taxes since 2022.

Best year ever: 2025, with € 287,595 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. ALISON PO KEE LEE, NEFROLOGIE? We notify you, reason included.

Follow DR. ALISON PO KEE LEE, NEFROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Alison Po Kee Lee

DR. ALISON PO KEE LEE, NEFROLOGIE

Behind DR. ALISON PO KEE LEE, NEFROLOGIE is Alison Po Kee Lee.

See the full network in the app

Directors

According to the 2025 annual accounts

Alison Po Kee Lee

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Renaat de Rudderlaan 14

2650 Edegem

2.242.879.134

Augustijnslei 100

2930 Brasschaat

Active since 8 June 2015

2.255.338.684

Oude Liersebaan 4

2390 Malle

Active since 31 December 2015

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CHENTI

€ 89,822 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0631.942.132
VAT number: BE 0631.942.132
Registered office: Renaat de Rudderlaan 14, 2650 Edegem
Names & denominations: DR. ALISON PO KEE LEE, NEFROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 June 2015
Peppol: Active · Active since 6 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗